APA (7th ed.) Citation

Johnson, D. W., Pascoe, E. M., Badve, S. V., Dalziel, K., Cass, A., Clarke, P., . . . Hawley, C. M. (2015). A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial. American journal of kidney diseases, 65(1), 49-57. https://doi.org/10.1053/j.ajkd.2014.06.020

Chicago Style (17th ed.) Citation

Johnson, David W., et al. "A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial." American Journal of Kidney Diseases 65, no. 1 (2015): 49-57. https://doi.org/10.1053/j.ajkd.2014.06.020.

MLA (9th ed.) Citation

Johnson, David W., et al. "A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial." American Journal of Kidney Diseases, vol. 65, no. 1, 2015, pp. 49-57, https://doi.org/10.1053/j.ajkd.2014.06.020.